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Introduction {#sec1}
============

Cell-cell fusion is ubiquitous across eukaryotes. It is required for fertilization, where two gametes of opposite type merge together to form a zygote ([@bib26]). During the development of multicellular organisms, the formation of syncytial tissues also occurs via fusion of somatic cells ([@bib71]). The molecular mechanism driving the merger of lipid bilayers has been studied extensively in the case of intracellular fusion events, such as the fusion of transport vesicles ([@bib38], [@bib47], [@bib62], [@bib68]) or the homotypic fusion of intracellular organelles ([@bib22], [@bib36]). In contrast, relatively little is known about extracellular fusion ([@bib35], [@bib55]). The only well-characterized extracellular fusion process is that of enveloped viruses, which fuse the viral lipid bilayer either with the plasma membrane or with an endosome from the luminal side ([@bib33]). HAP2/GCS1 is the first bona fide gamete fusion protein identified. Discovered in flowering plants ([@bib39], [@bib49]), subsequent studies in the green alga *Chlamydomonas reinhardtii* and the malaria organism *Plasmodium* showed that it was essential for bilayer merger ([@bib45]). The presence of HAP2 in organisms across the main branches of eukaryotes ([@bib14], [@bib18], [@bib41], [@bib60]) suggests that it is likely an ancestral gamete fusogen already present at the origin of eukaryotic life ([@bib70]). HAP2 is present exclusively in male gametes in most of the organisms where it was identified---or in minus type gametes in the case of isogamous organisms such as algae. The gamete fusion process has been studied in highest detail in *C. reinhardtii*, where HAP2 was shown to localize to the "mating structure", a projecting organelle at the plasma membrane located in between the two flagella of the *minus* gametes ([@bib50]).

We recently reported the X-ray structure of the *C. reinhardtii* HAP2 ectodomain. Although this structure lacked information about important functional regions, it revealed clear homology to class II viral fusion proteins ([@bib24]), a notion supported by parallel functional studies on HAP2 from other eukaryotic phyla ([@bib2], [@bib51], [@bib66]). The structural study also showed that the HAP2 ectodomain trimerizes upon insertion into membranes, adopting a hairpin arrangement typical of the post-fusion form of the viral proteins, with the transmembrane (TM) proximal region and the fusion loops together at one end of the trimer ([Figure 1](#fig1){ref-type="fig"}).Figure 1The New Structure Reveals Functional Species-Specific Regions of HAP2(A) Diagram illustrating the rearrangement of viral class II fusion proteins to catalyze membrane fusion. The three domains are colored red, yellow, and blue (for domains I, II, and III, respectively), the fusion loop orange, the stem magenta, and the TM segment gray. Viral and cellular membranes are in light and dark gray, respectively. (i) Prefusion arrangement, with the fusion loop buried at an oligomeric contact---a homo-dimer in the flaviviruses (as shown here, with the dimer partner striped for clarity---except that the flavivirus fusion protein spans the membrane twice) or a heterodimer with a companion protein (as in alphaviruses and bunyaviruses). (ii) Triggering of the fusogenic conformational change. The acidic environment of an endosome leads to dimer dissociation and exposure of the fusion loops. (iii) Extended intermediate bridging the two membranes. Multiple monomers at the viral surface insert into the target membrane with concomitant trimerization into an extended intermediate form, separating the two membranes at distances of about 15 nm. The curved arrows indicate the subsequent relocation of domain III to make a hairpin. (iv) Hairpin formation and pulling of the two membranes against each other. Domain III relocation to the side of the trimer redirects the stem toward the fusion loops, thereby pulling the two membranes against each other (gray arrows) to a distance within 1 nm, forcing outer leaflet dehydration to allow membrane contacts. Domain III relocation is accompanied by a domain I internal reorganization, indicated by a red square instead of a red circle. Several adjacent trimers are required to drive fusion ([@bib11]). (v) Fusion pore formation. Upon contact of the two membranes, fusion proceeds via an initial merger of the outer leaflets of the two membranes ("hemifusion", not shown) followed by formation of a fusion pore, as illustrated here.(B) The HAP2 ectodomain, crystallized in the post-fusion form (corresponding to panels iv and v in A). Left panel: the previously reported X-ray structure of a partially proteolyzed *C. reinhardtii* HAP2 ectodomain to 3.3 Å resolution. The foreground subunit is colored by domains as in (A). The intervening α0 helix is highlighted in brown (brown arrow). Disordered domain II loops are indicated by arrowheads. Black arrows at the bottom end mark the observed limits of the domain I C~0~D~0~ and E~0~F~0~ connections. Middle panel: ribbon representation of the new 2.6-Å resolution structure. The foreground subunit is shown in dark gray with regions not resolved previously highlighted in colors according to the domain they belong to as in (A). A central light blue bar marks the molecular 3-fold axis of the trimer. Right panel: the foreground subunit rotated as indicated and colored by domains to allow labeling the secondary structure elements buried in the trimer. In all panels, disulfide bonds are drawn as green sticks and N-linked glycan chains as sticks colored according to atom type (carbon, white; nitrogen, blue; and oxygen, red). A brown arrow in the middle and right panels marks the region of extended conformation that corresponds to the α0 helix in the left panel.(C) *C. reinhardtii* HAP2 aa sequence on a background colored by domains as in (A) and (B) and secondary structure elements marked. Regions not resolved in the previous structure are boxed. The remaining unstructured regions are on a white background. N-linked glycosylations are marked by full or empty blue stars for resolved sugar residues or disordered glycans, respectively. The gray arrow marks the last residue (592) in the HAP2e expression construct. A dashed box frames the proposed MPER.

In spite of being structurally unrelated, the three characterized structural classes of viral fusion proteins, termed classes I, II, and III ([@bib37]), were shown to function via a similar mechanism ([@bib32]). Anchored in the viral lipid envelope by a C-terminal TM segment, they have a bulky N-terminal ectodomain folded in a metastable conformation at the viral surface. Interactions with the target membrane trigger an exergonic conformational change during which the protein exposes a polypeptide segment, termed "fusion peptide" when it is N-terminal or "fusion loop" when it is internal. This segment inserts firmly into the outer leaflet of the target cell membrane while the protein adopts a transient, elongated trimeric conformation ([Figure 1](#fig1){ref-type="fig"}A). The trimer subunits then further re-organize into a hairpin that brings both membranes into close apposition (within 1 nm), thereby overcoming the repulsive force between the two membranes generated by the required dehydration of the outer leaflets to allow lipid contact, helping catalyze the membrane fusion reaction.

The reported HAP2 structure displayed the three characteristic β sheet-rich domains of viral class II fusion proteins, organized around the central domain I. In the post-fusion form, domain I is a 10-stranded β sandwich with the inner A~0~B~0~I~0~H~0~G~0~ β sheet packing against the outer J~0~C~0~D~0~E~0~F~0~ β sheet ([Figure 1](#fig1){ref-type="fig"}B). At the domain I "front" end, two of the connections between consecutive β strands make very long excursions to form the elongated domain II: the D~0~E~0~ connection spans domain II β strands *a'* through *e'*, while the H~0~I~0~ connection makes β strands *f* through *l* ([Figures 1](#fig1){ref-type="fig"}B and 1C). The fusion loops are located in the segment connecting β strands *c* and *d*, at the very tip of domain II. At the opposite end of domain I---the "bottom" end---a flexible linker connects to domain III, which has an immunoglobulin superfamily fold and is in turn connected to the C-terminal viral TM anchor via a flexible segment called "stem". Although the structure of HAP2 in the pre-fusion form is not known, structural studies on pre- and post-fusion forms of viral class II fusion proteins ([@bib5], [@bib27], [@bib29], [@bib31], [@bib48]) have shown that the transition mostly involves a rearrangement of the three domains with respect to each other, with domain III undergoing an important translation to re-locate to the sides of the trimer (diagrammed in [Figure 1](#fig1){ref-type="fig"}A). Importantly, in all cases studied, the central domain I undergoes the most significant internal rearrangement, with β strand A~0~ switching from the inner to the outer β sheet. This change is accompanied by formation of β strand J~0~, which in the pre-fusion form is part of the linker between domains I and III, and by a significant rearrangement of the A~0~B~0~, C~0~D~0~, and E~0~F~0~ inter-strand connections ([Figure 1](#fig1){ref-type="fig"}). These studies suggest that these same regions are also likely to undergo structural changes during the HAP2 trimerization to adopt its post-fusion form.

Although they drive fusion in an overall similar way, the viral fusion proteins of the various classes have different ways of ensuring a stable enough insertion into the target membrane to withstand the molecular gymnastics diagrammed in [Figure 1](#fig1){ref-type="fig"}A. In the case of the influenza virus hemagglutinin (HA) (the prototype class I fusion protein), the fusion peptide displays a random coil conformation in the pre-fusion form ([@bib69]), but restructures upon exposure to a membrane into an α-helical hairpin projecting nine bulky non-polar side chains ([@bib34], [@bib46]). In contrast, for certain class II proteins such as that of the Rift Valley fever virus (RVFV, a bunyavirus), the fusion loop maintains the same conformation it has in the pre-fusion form. In this case, a pre-formed pocket accommodates the head groups of glycerophospholipids of the membrane\'s outer leaflet by making multiple hydrogen bonds ([@bib29]). Combined with the insertion of only one or two bulky aromatic side chains of the fusion loop, these polar interactions provide stable enough anchoring to drive the fusion process.

Here, we report the X-ray structure of the *C. reinhardtii* HAP2 ectodomain derived from a different crystal form that resolves most of the regions that were missing in the previous structure. It shows that the fusion loops are folded as three amphipathic helices in a horseshoe-shaped arrangement. Mutagenesis altering the non-polar character of the exposed residues in the fusion helices disrupted the ability of the HAP2 ectodomain to insert into liposomes. This structure also showed the presence of an unanticipated cystine ladder-like (CLL) motif reminiscent of the epidermal growth factor (EGF)-like domains inserted in loop C~0~D~0~, packing against a mucin-like region in loop E~0~F~0~ at the bottom end of domain I.

Results {#sec2}
=======

Crystallization of the Intact HAP2 Ectodomain {#sec2.1}
---------------------------------------------

The crystals used to determine the previously reported HAP2 X-ray structure grew only after limited proteolysis of the HAP2 ectodomain ([@bib24]). Here we screened for crystallization conditions of the unproteolyzed HAP2 ectodomain in complex with HAP2-specific monoclonal antibodies obtained previously ([@bib24]). The complex with the single-chain variable fragment (scFv) of one of these antibodies resulted in crystals in the hexagonal space group P6~3~22 diffracting to 2.6 Å resolution ([Figure S1](#mmc1){ref-type="supplementary-material"}). Structure determination by molecular replacement using the atomic model of HAP2, PDB: [5MF1](pdb:5MF1){#intref0010}, resulted in an electron density map of HAP2 displaying one protomer per asymmetric unit (i.e., with the trimer axis coincident with a crystallographic 3-fold axis) and 80% of the volume occupied by solvent ([Table 1](#tbl1){ref-type="table"}). Unexpectedly, this map did not reveal density for a bound scFv. It is possible that formation of the crystal lattice displaced the bound antibody, or that it is present but disordered in the large solvent volumes in between HAP2 molecules ([Figure S1](#mmc1){ref-type="supplementary-material"}). In any event, the electron density allowed tracing the polypeptide chain for most of the HAP2 ectodomain, including loops that were not resolved in the available structure. In total, the new model contains 551 out of 573 residues ([Figure 1](#fig1){ref-type="fig"}B), with a break of about 15 residues in the *fg* loop in domain II---a loop projecting laterally, perpendicular to the trimer axis and roughly midway between top and bottom. Potential antibody binding to this loop could explain the absence of scFv density in the crystal, and will be the object of future experiments. Also missing was part of loop E~0~F~0~ at the trimer bottom ([Figure S1](#mmc1){ref-type="supplementary-material"}).Table 1Data Collection and Refinement StatisticsWavelength0.9785Resolution range39.0--2.6 (2.7--2.6)Space groupP6~3~22Unit cell a, b, c (Å)125.64, 125.64, 367.99 α, β, γ (°)90, 90, 120Total reflections75,352 (1,152)Unique reflections37,676 (604)Multiplicity2.0 (2.0)Completeness (%)70.66 (11.48)Mean I/sigma(I)12.32 (1.58)Wilson B factor54.09R~merge~0.05924 (0.4293)R~meas~0.08377 (0.6071)R~pim~0.05924 (0.4293)CC½0.995 (0.66)CC^∗^0.999 (0.892)Reflections used in refinement38,050 (604)Reflections used for R~free~1,909 (28)R~work~0.2244 (0.3323)R~free~0.2431 (0.3191)CC(work)0.921 (0.743)CC(free)0.866 (0.598)No. of non-hydrogen atoms4,136 Macromolecules3,943 Ligands111 Solvent82Protein residues529RMSD Bond length (Å)0.010 Bond angle (°)1.60Ramachandran plot (%) Favored97.32 Allowed2.49 Outliers0.19Rotamer outliers (%)1.37Clashscore1.75[^4]

Crystallographic refinement led to a final model containing 4,136 atoms in total, with free R factor of 24.3% at 2.6 Å. Comparison of the new model with the previously determined structure resulted in a root-mean-square deviation of 0.53 Å for 528 aligned Cα atoms, indicating that they are very close, with minor changes at the tip of domain II, where the proteolytic treatment to obtain the crystals may have locally affected the protein conformation.

Potential Protein-Protein Interaction Modules in Domain I {#sec2.2}
---------------------------------------------------------

### Mucin-like Region {#sec2.2.1}

The new crystals revealed density for loops C~0~D~0~ and E~0~F~0~ ([Figure 2](#fig2){ref-type="fig"}). These two segments are highly variable in sequence and length in HAP2 orthologs across eukaryotes ([Figures S2](#mmc1){ref-type="supplementary-material"} and [S3](#mmc1){ref-type="supplementary-material"}), and are particularly long in HAP2 from green algae. In *C. reinhardtii* HAP2, the longest is loop E~0~F~0~ (residues 239--284), a 45-residue-long segment rich in proline and serine/threonine residues ([Figure S2](#mmc1){ref-type="supplementary-material"}A), which are typical of heavily O-glycosylated proteins such as the mucins ([@bib59]) ([Figure 2](#fig2){ref-type="fig"}A, left panel, and [Figure S2](#mmc1){ref-type="supplementary-material"}A). Mucin-like regions (MLRs), which are known to confer unique rheological properties on proteins ([@bib63]), are present on viral proteins involved in attachment to cells, for instance in glycoprotein C of herpes simplex viruses ([@bib52]), the respiratory syncytial virus glycoprotein G ([@bib56], [@bib67]), or in the surface glycoprotein of Ebola virus ([@bib43]). These viral proteins have in common the recognition and binding of glycosaminoglycans (GAGs) present at the surface of target cells, and the MLR was shown to modulate GAG binding ([@bib1]). In animals, MLRs are found on many proteins anchored at the cell surface, as well as in secreted proteins, and were found to modulate cell recognition and adhesion via sugar/lectin interactions ([@bib65]). Although the new crystals did not entirely resolve the E~0~F~0~ loop, they showed density for its N-terminal six amino acids (aa) (sequence PTAPSP, downstream of strand E~0~) as well as its C-terminal 14 residues (271-APQFLSPPAPSTRE-285) preceding β strand F~0~ ([Figure 2](#fig2){ref-type="fig"}A), accounting in total for 40% of the loop. The latter proline-rich segment packs against the bottom of domain I, and also contacts loops A~0~B~0~ and C~0~D~0~ of the neighboring subunit. Of note, the downstream F~0~ and G~0~ β strands in the previously reported structure were misassigned and were out of register by two residues, due to poor electron density in this region and the more limited resolution of those crystals. In addition, the density that had been interpreted as a potential O-glycosylation on residue Thr577 at the end of domain III, is clear in the new structure to correspond to an N-linked glycan attached to Asn578. These errors were corrected in the present structure.Figure 2MLR and CLL Motifs in Domain I(A) The HAP2 trimer is shown at the center with boxes indicating the two insets, the E~0~F~0~ (left) and C~0~D~0~ (right) loops. Left panel: the dashed curved line represents the disordered central region of the E~0~F~0~ loop (residues 245--270), with its mucin-like sequence displayed underneath with N-linked glycosylation sequons marked with empty blue stars. Right panel: the CLL motif in the C~0~D~0~ loop with the disulfides drawn in green and labeled as in [Figure 1](#fig1){ref-type="fig"}C.(B) Sequence alignment of the CLL motif showing its conservation across green algae, with cysteines in green indicating the disulfide connectivity. One of the sequences has a 5 residue insertion (Blue background). See the [STAR Methods](#sec4){ref-type="sec"} for abbreviations.(C) Surface electrostatic potential of the CLL motif displayed on a scale of −1 to 1 kT/e, from red (acidic) through neutral (white) to basic (blue).(D) The C~0~D~0~ loop CLL is shown at the center, next to an authentic cystine ladder motif as observed in θ defensins ([@bib15]) (left panel) and to an EGF-like module. The cysteines are numbered sequentially to show the different connectivity of the disulfide bonds (green).

### CLL Motif {#sec2.2.2}

The 37-residue long C~0~D~0~ loop is completely resolved in the new structure, and displays a CLL motif with three parallel disulfide bonds ([Figure 2](#fig2){ref-type="fig"}A, right panel). This motif is present only in HAP2 from green algae ([Figure S3](#mmc1){ref-type="supplementary-material"}), across which it is highly conserved ([Figure 2](#fig2){ref-type="fig"}B). Authentic cystine ladder motifs have been observed in θ defensins ([@bib15]), which are 18-residue long cyclic peptides with antifungal, antibacterial, and antiviral activities first isolated from primates ([@bib64]). The CLL motif in the C~0~D~0~ loop is however more reminiscent of EGF-like domains ([Figure 2](#fig2){ref-type="fig"}D), which are extracellular modules identified in animals, found as single or as multiple copies connected sequentially ([@bib4]). Protein-protein contacts involving EGF-like modules are associated with blood coagulation, complement activation, cell adhesion, or determination of embryonic cell fate during animal development ([@bib4], [@bib10], [@bib61]). These domains are also around 40 aa long and contain 6 conserved cysteine residues forming three disulfide bonds. The arrangement of these bonds is intermediate between the CLL and the "cystine knot motif" observed in many bioactive peptides ([@bib16]). In HAP2, the CLL motif is inserted at the turn of a β hairpin formed by domain I consecutive β strands C~0~ and D~0~, and so the N and C termini are next to each other ([Figure 2](#fig2){ref-type="fig"}D, middle panel). In contrast, the "chain of beads" organization of proteins containing sequential EGF-like domains directs their termini to opposite ends ([Figure 2](#fig2){ref-type="fig"}D, right panel). This different topology results in a change in the disulfide connectivity, with a 1--3, 2--4, and 5--6 bonding pattern in EGF-like modules and 1--2, 3--6, and 4--5 in the HAP2 CLL ([Figure 2](#fig2){ref-type="fig"}B). The HAP2 C~0~D~0~ loop displays an electrostatically charged surface potential ([Figure 2](#fig2){ref-type="fig"}C)---a hallmark of EGF-like modules---although the CLL does not display the Ca^2+^ binding motif present in a subset of the EGF-like domains ([@bib53]).

The Stem Region {#sec2.3}
---------------

Another region that had not been resolved previously is the stem segment that connects domain III to the C-terminal TM helix. The new structure resolves the N-terminal 12 residues of the stem, showing that it is directed toward the tip of domain II of the adjacent "left" subunit in the trimer ([Figure 3](#fig3){ref-type="fig"}). Compared with the two viral class II proteins for which the stem is resolved, RVFV Gc and rubella virus (RV) E1, the path of the stem to reach the fusion loops in the HAP2 post-fusion trimer is different. In spite of a similar positioning of domain III, the stem does not turn back to interact with domain II from the same protomer (yellow in [Figure 3](#fig3){ref-type="fig"}) as in RVFV. HAP2 is also different to RV E1, as in this case not only the stem but also domain III interacts with the alternative adjacent subunit (to the "right" in the trimer; [Figure 3](#fig3){ref-type="fig"}, right panel). The HAP2 stem fills a surface groove in the adjacent protomer, formed between the *bc* loop and the *aefg* β sheet of domain II. The polar contacts include a short segment of antiparallel main-chain β interactions (strand *m,* residues 587--589; [Figures 1](#fig1){ref-type="fig"}B and 1C) with the *bc* loop, inducing formation of strand *s* (residues 149--151; [Figure 3](#fig3){ref-type="fig"}, inset). The construct used for crystallization ended at residue G592, followed by the affinity tag. The last residue ordered in the structure is N591 ([Figure 1](#fig1){ref-type="fig"}C), with the stem ending roughly at the level of the *bdc* β sheet in the domain II tip. In full-length *C. reinhardtii* HAP2, there are 42 aa between this point and the TM helix, including an amphipathic membrane proximal external region (MPER). Comparison with the viral proteins ([Figure 3](#fig3){ref-type="fig"}) suggests that the distance remaining to reach the fusion loops would be spanned by about 10--12 residues, until about position 604. The sequence of the remaining C-terminal part (residues 605--633, [Figure S4](#mmc1){ref-type="supplementary-material"}) is compatible with the MPER present in a number of viral fusion proteins ([@bib9], [@bib30], [@bib59]). The MPER has so far eluded structural characterization for any fusion protein in the context of the post-fusion form (the MPER is not represented, for clarity, in the diagram of [Figure 1](#fig1){ref-type="fig"}A).Figure 3The Stem Inserts into an Adjacent Subunit Domain II GrooveHAP2 displayed next to the viral class II glycoproteins for which the stem is resolved: RVFV Gc (PDB: [6EGU](pdb:6EGU){#intref0160}) and RV E1 (PDB: [4ADI](pdb:4ADI){#intref0165}) in their post-fusion conformation. In HAP2, the stem interacts with domain II of the "left" subunit in the trimer. In RVFV, it interacts with domain II of the same subunit (in yellow). In the RV E1 trimer, both domain III and the stem interact with the subunit to the right. For context, a fused membrane is schematized at the top, with hydrophilic and aliphatic moieties in light and dark gray, respectively. The inset (left panel) shows a more detailed view of the stem (magenta) inserted in the groove formed by the *bc* loop and *aefg* β sheet of the adjacent protomer (gray). Dashed lines represent inter-chain hydrogen bonds between the stem and domain II.

The HAP2 Membrane Insertion Region {#sec2.4}
----------------------------------

The packing between HAP2 trimers in the new crystals involves 2-fold symmetric head-to-head interactions along the 3-fold crystallographic axis ([Figure S1](#mmc1){ref-type="supplementary-material"}). This "dimer of trimers" is likely to correspond to the "hexamer" observed in the size-exclusion chromatography (SEC) profile of the purified recombinant HAP2 ectodomain ([Figure S1](#mmc1){ref-type="supplementary-material"}A, left panel). In this assembly, the non-polar residues at the tip of domain II are masked from solvent. This interaction between trimers results in the fusion loops being entirely resolved in the new structure. The segment between β strands *c* and *d* of domain II, which is 40 residues long, projects two loops (*cd1* and *cd2* in [Figure 3](#fig3){ref-type="fig"}B) exposing non-polar side chains. In place of the single αF fusion helix observed in *A. thaliana* HAP2 and the three potential short fusion loops of *T. cruzi* HAP2 ([Figure 4](#fig4){ref-type="fig"}A), in *C. reinhardtii* the HAP2 membrane insertion surface is composed of helix αF1 in loop *cd1* and αF2 in *cd2*, running roughly antiparallel to each other ([Figure 5](#fig5){ref-type="fig"}, left panels), and a small 3~10~ helix (ηF) also in loop *cd2* directly preceding αF2. The three "fusion helices" are arranged into a horseshoe shape, exposing the non-polar residues toward the target membrane ([Figures 4](#fig4){ref-type="fig"} and [5](#fig5){ref-type="fig"}). αF1 is 9 aa long and exposes residues W173 and F177; ηF is only one turn and exposes F192 and W193, and αF2 is 7 aa long and exposes P196, L197, L200, and I201 ([Figure 4](#fig4){ref-type="fig"}). In addition to providing a firm hold of the protein onto the target membrane, the substantial membrane insertion surface is likely to generate a significant stress upon insertion into the outer leaflet of the opposing gamete membrane. The resulting lipid bilayer destabilization can potentially also play a role in facilitating the downstream membrane fusion process.Figure 4The *C. reinhardtii* HAP2 Membrane Insertion Surface(A) The tip of *C. reinhardtii* HAP2 domain II (left) compared with the corresponding region in *A. thaliana* (center) and *T. cruzi* (right) ([@bib23]). The helices in fusion loops 1 and 2 are colored beige and yellow. Broken orange lines mark a two-residue disordered segment in the *bc* loop in *T. cruzi* HAP2 that could potentially also insert into the target membrane. The panels were aligned on the conserved salt bridge (indicated by a continuous horizontal line), showing that the membrane would be at a variable distance from the *bdc* core β sheet (the horizontal dashed lines mark roughly the limits of the polar moiety of the membrane\'s outer leaflet). This figure highlights the potential malleability of the membrane insertion surface.(B) Surface representation of the HAP2 trimer tip colored by hydrophobicity. The gray stripe indicates a roughly polar head group layer of the membrane. Note the space left at the center by the projecting domain II tips of the three trimer subunits, seen on the right panel by depth cueing with white fog.(C) Membrane binding analysis of *C. reinhardtii* wild-type (WT) and fusion helix mutants of HAP2 by liposome co-flotation assays on iodixanol gradients (Optiprep). Top (T) and bottom (B) fractions of the gradients were analyzed by western blotting for the presence of the HAP2 ectodomain. The right panels show the quantification of HAP2e detected in the gradient fractions. The values represent the average of three independent experiments ± SD, analyzed by Student\'s t test. Levels of significance are: ^∗^p \< 0.05; ^∗∗^p \< 0.01; NS, not significant.Figure 5Comparison of the *C. reinhardtii* HAP2 fusion surface with viral counterpartsThe HAP2 fusion loops (left panel) form a platform projecting hydrophobic residues. As similar platform is formed by the fusion peptide of the class I influenza virus hemagglutinin (PDB: [2KXA](pdb:2KXA){#intref0170}) (second panel). The fusion loop of the RVFV (PDB: [6EGU](pdb:6EGU){#intref0175}) or the flavivirus fusion protein (PDB: [1OK8](pdb:1OK8){#intref0180}) (right panels) is significantly less extensive.

The HAP2 *cd* segment is long in comparison with the *cd* loop of the fusion protein of the well-studied flaviviruses (10 residues) ([@bib48]) or bunyaviruses such as RVFV (15 residues) ([@bib29]), but not when compared with other class II viral fusion proteins. For instance, RV E1 has a 48-aa-long *cd* inter-strand connection ([@bib17]), featuring an additional β strand (*c'*) that augments the *bdc* β sheet at the domain II tip into *bdcc'* and exposes two fusion loops, *cc'* and *c\'d* ([Figure 3](#fig3){ref-type="fig"}B). In HAP2, *cd1* and *cd2* are separated by the arginine residue ([Figure 4](#fig4){ref-type="fig"}A) making a strictly conserved salt bridge (R185-E126 in *C. reinhardtii* HAP2) with a glutamic acid in β strand *b* ([@bib24]). This salt bridge is a distinctive HAP2 feature among all class II proteins, linking the variable membrane insertion region to the highly conserved core of the protein ([@bib23]). The R185 side chain not only makes a salt bridge but also donates multiple hydrogen bonds to backbone carbonyls of the highly conserved "*ij* loop" ([Figure 4](#fig4){ref-type="fig"}A), so named because it takes the place of the *ij* β hairpin of viral class II proteins. The HAP2 *ij* loop is the central part of the pfam 10699 motif ([@bib25]), a ∼50-aa-long stretch of conserved sequence that allowed the identification of HAP2 in numerous eukaryotic species.

Although the aa 184--190 stretch (i.e., including the conserved R185) in between *cd1* and *cd2* was ordered in the previous structure and formed an α helix termed α0, it displays an extended conformation in the new structure ([Figures 1](#fig1){ref-type="fig"}B and [4](#fig4){ref-type="fig"}A, left panel). This segment is also extended in *Arabidopsis thaliana* HAP2 ([Figure 4](#fig4){ref-type="fig"}A, middle panel) ([@bib23]). The difference between the two *C. reinhardtii* HAP2 structures in this stretch could have been induced by the *in situ* proteolytic treatment used to grow the initial crystals. α0 helix folding/unfolding could also be a mechanism required to fully project the *cd* loop toward the target membrane during the fusogenic conformational change of HAP2. Indeed, the crystal structure of domain II of *T. cruzi* HAP2 does display an α0 helix in the same location and orientation ([Figure 4](#fig4){ref-type="fig"}A, right panel). In contrast to the fusion helices, α0 runs perpendicular to the target membrane. The only non-polar bulky residues present at the membrane insertion region are in the second turn of the *T. cruzi* HAP2 α0 helix, and are not fully exposed ([Figure 4](#fig4){ref-type="fig"}A, third panel), suggesting that this segment may have adopted an alternative conformation in the aqueous environment used for crystallization ([@bib23]).

The Non-polar Residues of the Fusion Helices Are Required for Liposome Binding {#sec2.5}
------------------------------------------------------------------------------

Our previous results demonstrated that gamete fusion *in vivo* correlates with the ability of HAP2 to insert into liposomes *in vitro* ([@bib24], [@bib23]). To confirm that the exposed residues of the fusion helices are indeed important for membrane insertion, we examined the behavior of the HAP2 ectodomain and of selected mutants in liposome co-flotation in density gradients, as described in the [STAR Methods](#sec4){ref-type="sec"} section. All the mutants tested were similar to wild-type in terms of expression yields and transit through the quality control system of the producer cells for secretion. The SEC profiles of the mutants were also similar to wild-type, indicating that the introduced mutations did not induce any obvious misfolding, as expected for exposed residues such as those being tested.

As P196 induces an important kink causing the shift from ηF to αF2 in loop *cd2*, we tested the effect of the P196A mutation and found that there were no statistically significant differences with wild-type ([Figure 4](#fig4){ref-type="fig"}C) in liposome co-flotation. The kink induced by P196 in the conformation of the fusion helices is thus not essential for insertion into membranes. In contrast, we found a more drastic effect when we substituted the non-polar residues by histidine, a polar aa. Indeed, the double mutants W173H/F177H (αF1), W192H/F193H (ηF), and the triple mutant L197H/L200H/I201H (αF2), displayed essentially no detectable liposome binding. The triple mutant L197Q/L200Q/I201Q had the same effect, suggesting that any polar side chain replacing the non-polar bulky side chains of these helices will interfere with membrane binding, as expected. This last result is also an important control, as the introduction of multiple neighboring histidines could induce local repulsion upon their protonation, although the membrane binding assays were done at pH 7.4 and the pK~a~ of solvent-exposed histidine side chains is 6.8. Of note, in contrast to virus fusion driven by class II fusion proteins, which takes place in the acidic environment of the endosomes, *Chlamydomonas* gamete fusion occurs in the extracellular environment at neutral pH.

When the same bulky non-polar residues were replaced by alanine, which has a small non-polar side chain, the effect on membrane insertion was less striking: the difference in binding of double mutant W192A/F193A in ηF was less significant with respect to wild-type, and W173A/F177A (αF1) or L197A/L200A/I201A (αF2) displayed reduced binding although not as significant as the mutants with polar residues. It required a mutant with alanine substitution in both, αF1 and ηF, W176A/F177A/W192A/F193A, for a complete loss of binding comparable with the experiments involving substitution by polar residues ([Figure 4](#fig4){ref-type="fig"}C). These experiments therefore demonstrate that the bulky non-polar residues of the fusion loops indeed control the insertion of the HAP2 ectodomain into lipid bilayers. The differences observed when substituting them to alanine instead of polar residues suggest that certain positions are key anchoring sites requiring a bulky non-polar side chain, whereas others are necessary only to maintain the non-polar character of the surface. This is demonstrated in particular by the significant difference in insertion to liposomes of the mutant W173A/F177A compared with W192A/F193A ([Figure 4](#fig4){ref-type="fig"}C, bottom panels).

Discussion {#sec3}
==========

The X-ray structure of the *C. reinhardtii* HAP2 ectodomain described here has higher resolution and provides views of important functional regions that were not resolved in the previously reported structure. One crucial segment that was missing is the tip of domain II and its fusion loops, which must insert into the target membrane and are critical for the membrane fusion function of HAP2. The new structure shows that the domain II tip exposes a hydrophobic platform formed by three short helices projecting ten bulky non-polar residues that are used for membrane insertion ([Figure 1](#fig1){ref-type="fig"}A, steps ii to v). This region is involved in hydrophobic head-to-head interactions between two HAP2 trimers to form the crystals ([Figure S1](#mmc1){ref-type="supplementary-material"}B), making a dimer of trimers that was also observed in solution ([Figure S1](#mmc1){ref-type="supplementary-material"}A, left panel).

The arrangement of the membrane insertion surface in *C. reinhardtii* HAP2 is reminiscent of the α-helical hairpin of the influenza virus HA fusion peptide, which projects nine bulky non-polar residues ([Figure 5](#fig5){ref-type="fig"}, second panel) into the target membrane (reviewed in [@bib3]). This structure forms only upon interaction of the HA fusion peptide with the outer leaflet of the membrane, whereas in HAP2 the helical arrangement appears to be pre-formed in the protein. An important difference is that in HA the two antiparallel amphipathic helices pack very tightly against each other, whereas in HAP2 they have a rather loose, horseshoe-shaped arrangement. The HAP2 fusion loops are also very different to those of the viral class II proteins that have been characterized, such as the fusion proteins of flaviviruses---i.e., dengue virus E ([@bib44], [@bib48]), of Gc from bunyaviruses such as RVFV ([@bib29]) ([Figure 5](#fig5){ref-type="fig"}, right panels), and also to the RV E1 fusion loops ([Figure 3](#fig3){ref-type="fig"}B). Molecular dynamics analyses using RVFV Gc showed that insertion of the fusion loop involves a rearrangement of the membrane such that the bulky lipid head groups move apart to avoid clashes with the main chain of the inserted loop. In addition, the presence in the membrane of lipids with very small polar heads was required to fill the void created in the aliphatic moiety at the site of insertion. This effect would be more drastic in the case of *C. reinhardtii* HAP2 as the inserted motif is much larger (compare panels in [Figures 4](#fig4){ref-type="fig"}A and [5](#fig5){ref-type="fig"}). We note that the tips of the three domains II in the HAP2 trimer leave an empty space at the center ([Figure 4](#fig4){ref-type="fig"}B), which we propose is important to accommodate the displaced bulky lipid head groups upon insertion of the fusion helices. In influenza virus HA2, the tight α-helical platform of the fusion peptide is loosely tethered via a flexible linker to the central, rigid trimeric α-helical coiled coil of the HA2 subunit of HA ([@bib8], [@bib12]), providing flexibility and leaving space to accommodate the displaced lipid head groups. In HAP2, not only the lateral packing of the fusion helices appears to be loose (the minor effect of the P196A mutation in liposome binding shown in [Figure 4](#fig4){ref-type="fig"}C indeed suggest that this region displays conformational malleability), but their connection to the rigid *bdc* β sheet of the domain II tip also displays flexibility ([Figure 4](#fig4){ref-type="fig"}A) that is potentially important for membrane insertion. The relatively flexible connection to the *bdc* β sheet could combine with a potential rocking about the strictly conserved R185-E125 salt bridge ([Figure 4](#fig4){ref-type="fig"}A). The malleability of this region is further exemplified by formation or not of a vertical α0 helix around the R185 position. We also note that sequence analysis of the HAP2 fusion loop region further suggests that the three fusion helices are not conserved in many algae ([Figure S5](#mmc1){ref-type="supplementary-material"}), and some appear to have a single fusion helix, similar to HAP2 from the flowering plants ([@bib23]). Future studies using molecular dynamics simulations and taking advantage of the currently available X-ray structures of three orthologs should be useful to better understand the HAP2 membrane insertion process.

A driver for the high variability observed in certain regions of HAP2 may be the requirement of barriers that avoid cross-species fertilization. In the viral class II proteins, the fusion loops are exposed only at the time of fusion, and until this moment the protein is maintained in a metastable conformation via interaction with itself (as diagrammed in [Figure 1](#fig1){ref-type="fig"}A, panel i) or most commonly with other proteins, such that that the fusion loops are masked ([@bib30], [@bib42]). The high sequence variability of the HAP2 fusion loops could thus be driven by its necessary interaction with species-specific proteins that recognize and bind to this region. The controlled release of their grip on HAP2 could then be a way to trigger its fusogenic conformational change and exposure of the fusion helices (corresponding to panel ii in [Figure 1](#fig1){ref-type="fig"}A). In our *in vitro* experiments, in the absence of the putative interacting molecules normally present in the *in vivo* situation, the recombinant HAP2 ectodomain is triggered spontaneously to change conformation, with monomers trimerizing irreversibly in solution to form post-fusion trimers that interact head-to-head ([Figure S1](#mmc1){ref-type="supplementary-material"}). The remaining monomers in our preparations remain competent for membrane insertion, by forming membrane-inserted post-fusion trimers when incubated with liposomes ([@bib24], [@bib23]). Cellular fusion events are normally controlled such that they can take place fast but only at the required time and space. This is demonstrated, for instance, in neurotransmitter release, where the fusogenic SNARE proteins are controlled by an array of other synaptic proteins that allow for very fast fusion of vesicles that are pre-bound at the cytosolic side of the plasma membrane. The rate-limiting steps involved in priming the fusion machinery have already taken place when a signal provided by calcium influx activates fusion ([@bib7]). In the case of HAP2-driven gamete fusion, our results now suggest that, in addition to fusion loop masking, there may be additional controls at other steps---such as trimerization, which involves rearrangements in the bottom end of domain I. Our data further suggest additional potential means of identifying interaction partners of HAP2 *in vivo*, for instance by comparative co-immunoprecipitation using HAP2 wild-type and variants mutated at key sites at the domain I bottom.

STAR★Methods {#sec4}
============
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-------------------

REAGENT or RESOURCESOURCEIDENTIFIER**Antibodies**A20This studyRRID: [AB_2749850](nif-antibody:AB_2749850){#interref9070}**Deposited Data***C. reinhardtii* HAP2 ectodomain structureThis studyPDB: [6E18](pdb:6E18){#intref0015}*C. reinhardtii* HAP2 *in situ* proteolyzed ectodomain[@bib24]PDB: [5MF1](pdb:5MF1){#intref0020}**Experimental Models: Cell Lines***D. melanogaster* S2 cell lineThermo-FisherCat \# R690-07Expi293F cellsThermo-FisherA14635**Recombinant DNA**pMT/BiP/TwinStrepN/ApcDNA3.1(+)/CD5sp/TwinStrepN/A**Software and Algorithms**XDS[@bib40]<http://xds.mpimf-heidelberg.mpg.de/>CCP4Collaborative Computational\
Project, 1994<http://www.ccp4.ac.uk/>Phaser[@bib73]<http://www.phaser.cimr.cam.ac.uk/index.php/Phaser_Crystallographic_Software>Coot[@bib20]<https://www2.mrc-lmb.cam.ac.uk/personal/pemsley/coot/>AutoBuster[@bib6]<https://www.globalphasing.com>StaranisoGlobal Phasing Limited<http://staraniso.globalphasing.org/cgi-bin/staraniso.cgi>MolProbity[@bib13]<http://molprobity.biochem.duke.edu/>PymolMolecular Graphics System, Schrodinger, LLC<https://pymol.org/2/>Heliquest[@bib72]<http://heliquest.ipmc.cnrs.fr/>ImageJ[@bib57][https://imagej.nih.gov/ij/](https://ImageJ.nih.gov/ij/){#intref0070}**Other***Chlamydomonas reinhardtii*Uniprot: A4GRC6N/A*Gonium pectoral*Uniprot: X5IBH0N/A*Volvox carteri* form AUniprot: D8U2H4N/A*Monoraphidium neglectum*Uniprot: A0A0D2MSE3N/A*Volvox carteri* form BUniprot: D8U2H3N/A*Coccomyxa subellipsoidea*Uniprot: I0Z782N/A*Chlorella variabilis*Uniprot: E1Z455N/A*Chlorella sorokiniana*Uniprot: A0A2P6TVX6N/A*Micractinium conductrix*Uniprot: A0A2P6VMS5N/A*Auxenochlorella protothecoides*Uniprot: A0A1D2A410N/A*Cyanidioschyzon merolae*GenBank: [XP_005536505.1](ncbi-p:XP_005536505.1){#interref9010}N/A*Selaginella moellendorfii*GenBank: [XP_002971451.1](ncbi-p:XP_002971451.1){#interref9015}N/A*Arabidopsis thaliana*Uniprot: AAY51999.1N/A*Capsella rubella*GenBank: [XP_006289435.1](ncbi-p:XP_006289435.1){#interref9020}N/A*Erythranthe guttata*GenBank: [XP_012846387.1](ncbi-p:XP_012846387.1){#interref9025}N/A*Solanum lycopersicum*GenBank: [XP_019070618.1](ncbi-p:XP_019070618.1){#interref9030}N/A*Lilium longiflorum*Uniprot: BAE71142.1N/A*Zea mays*GenBank: [XP_020531486.1](ncbi-p:XP_020531486.1){#interref9035}N/A*Oryza sativa*Uniprot: BAF16968.1N/A*Amborella trichopoda*GenBank: [XP_020531486.1](ncbi-p:XP_020531486.1){#interref9040}N/A*Toxoplasma gondii*UniProt: KYF43852.1N/A*Plasmodium falciparum*GenBank: [XP_001347424.1](ncbi-p:XP_001347424.1){#interref9045}N/A*Eimeria tenella*Uniprot: BAM16295.1N/A*Tetrahymena thermophila*Uniprot: AIA57699.1N/A*Paramecium tetraurelia*Uniprot: CAK65033.1N/A*Trypanosoma cruzi*Uniprot: EAN93043.1N/A*Trypanosoma congolense*Uniprot: CCC94129.1N/A*Trypanosoma brucei*Uniprot: EAN78468.1N/A*Leishmania major*GenBank: [XP_003722443.1](ncbi-p:XP_003722443.1){#interref9050}N/A*Dictyostelium discoideum*Uniprot: BAS29571.1N/A*Physarum polycephalum*Uniprot: BAE71144.1N/A*Monosiga brevicolis*Uniprot: EDQ88884.1N/A*Nematostella vectensis*Uniprot: EDO36432.1N/A*Hydra vulgaris*GenBank: [XP_004211319.2](ncbi-p:XP_004211319.2){#interref9055}N/A*Capitella teleta*Uniprot: ELU07639.1N/A*Tribolium castaneum*Uniprot: EFA06462.1N/A*Acyrthosiphon pisum*GenBank: [XP_016661643.1](ncbi-p:XP_016661643.1){#interref9060}N/A*Orchesella cincta*Uniprot: ODN05384.1N/A*Saccoglossus kowalevskii*GenBank: [XP_006821859.1](http://XP_006821859.1){#interref9065}N/A

Contact for Reagent and Resource Sharing {#sec4.2}
----------------------------------------

Further information and requests for reagents may be directed to and will be fulfilled by the Lead Contact, Félix A. Rey (<felix.rey@pasteur.fr>).

Experimental Model and Subject Details {#sec4.3}
--------------------------------------

### Insect Cell Culture {#sec4.3.1}

Drosophila S2 cells were maintained in flasks at 28°C in HyClone medium (GE Healthcare Life Sciences) supplemented with 50 units/mL of penicillin, 50 units/mL of streptomycin and 7 μg/mL of puromycin for selection of stable transfectans. Large-scale cultures for protein production were grown in spinner flasks at 100 rpm. No information on the sex of these cells is available.

### Mammalian Cell Culture {#sec4.3.2}

Expi293F cells were grown at 37°C in Expi293 expression medium (Thermo Fisher) with rotary agitation at 135 rpm. No information on the sex of this cell line is available.

Method Details {#sec4.4}
--------------

### Expression Construct for the Single Chain Variable Fragment (scFv) of Monoclonal Antibody A20 {#sec4.4.1}

Monoclonal antibodies targeting *C. reinhardtii* HAP2 were generated as described previously ([@bib24]). For sequencing of the antibody variable regions total RNA was prepared from A20 hybridoma cells and cDNA was synthesized using separate constant region primers for heavy and light chain. Variable regions of heavy and light chain genes were subsequently amplified using gene-specific primers and subcloned into a plasmid for insect cell expression of scFvs described previously ([@bib28]).

### Protein Expression and Purification {#sec4.4.2}

*Drosophila* S2 stable cell lines expressing soluble C-terminally truncated *Chlamydomonas reinhardtii* HAP2 ectodomain (residues 23-592), were generated to obtain high yields of recombinant proteins for crystallization experiments ([@bib24]). The expression construct included an enterokinase cleavage site (sequence DDDDK) immediately downstream HAP2 G592. at the C-terminal end of the ectodomain, followed by a double strep-tag for purification. The expression of the protein is under the control of metallothionein promoter, which is induced by adding 4 μM CdCl2 to the cell culture medium when the cell density reaches approximately 7x10^6^ cells/ml. At 5 days post-induction, the cells were pelleted and the soluble ectodomain was purified by affinity chromatography from the supernatant on a *StrepTactin Superflow* column. The strep tag was then removed by treatment with enterokinase and the protein was further purified by SEC on a *Superdex200* column equilibrated with 10 mM bicine pH 9.3. As we reported previously ([@bib24]), low ionic strength conditions at pH 9.3 reduce formation of HAP2 hexamers. As shown in [Figure S1](#mmc1){ref-type="supplementary-material"}, hexamers appear to form by head-to-head interaction between two trimers via the hydrophobic fusion loops, thus interfering with HAP2 binding to membranes.

The yields of HAP2 ectodomain obtained from S2 cells were around 15 mg/l of cell culture. The purified protein was concentrated to approximately 5 mg/ml.

We also generated an S2 stable cell line expressing antibody A20 scFv, which was expressed following the same procedures used for the HAP2 ectodomain. The complex between the HAP2 ectdomain and scFv A20 was obtained mixing both proteins in a molar ratio 1:2 and incubating overnight at 4°C. The HAP2-scFv A20 complex was then separated from unbound scFv on a Superdex200 column. The fractions in [Figure S1](#mmc1){ref-type="supplementary-material"}, right panel, corresponding to the complex were pooled and then concentrated to approximately 7 mg/ml.

### Crystallization and Structure Determination {#sec4.4.3}

Crystals were grown using the sitting drop method at 293K by mixing HAP2-scFv A20 protein solution in a ratio 1:1 with reservoir solution containing 0.2M LiSO~4~, 0.1M Tris-HCl pH 8.5 and 25% w/v PEG 5000 MME. Small hexagonal plates obtained after 5 days were cryoprotected with reservoir solution containing 15% glycerol and plunged in liquid nitrogen.

Data collection was carried out at the SOLEIL synchrotron (St Aubin, France). Data were processed, scaled and reduced with XDS ([@bib40]) and AIMLESS ([@bib21]). Diffraction anisotropy was corrected with DEBYE and STARANISO programs using the STARANISO server (<http://staraniso.globalphasing.org/>). These programs perform an anisotropic cut-off of merged intensity data, a Bayesian estimation of structure amplitudes and apply an anisotropic correction to the data. The HAP2 structure was determined by molecular replacement using PHASER and the coordinates of the previous crHAP2e ectodomain (PDB accession code [5MF1](pdb:5MF1){#intref0145}) as search model. The model was corrected and completed using COOT ([@bib20]) and the corrected anisotropic amplitudes were used for model refinement in BUSTER ([@bib6]). The stereochemical properties of the model were validated with MolProbity ([@bib13]).

### Design and Expression of HAP2 Fusion Loops Mutants {#sec4.4.4}

Recombinant HAP2 ectodomain and fusion loops mutants for liposome co-flotation experiments were obtained by transient transfection of mammalian cells, by using the pcDNA3.1(+) plasmid with the gene coding for the HAP2 ectodomain (residues 23-592) followed by a double strep-tag at the C-terminal end of the ectodomain. Mutants at positions 173, 177, 192, 193, 197, 200 and 201 were generated by standard PCR methods. Expi293 cells were transfected with WT or mutant constructs using polyethylenimine (PEI, 1 mg/ml) in a DNA:PEI ratio 1:4. Cell culture supernatants were harvested at 5 days post-transfection and protein was purified by affinity chromatography as mentioned above. As for the protein produced in S2 cells, the purified proteins were buffer exchanged to 10 mM bicine pH 9.3 and concentrated to 1 mg/ml, to minimize hexamer formation.

The yields of HAP2 WT expressed in mammalian cells were around 200 μg of pure protein per 30 ml of cell culture. The yields of all HAP2 fusion loop mutants tested were in the range of 1 to 2 times the yields of the WT protein.

### Liposome Co-flotation Experiments {#sec4.4.5}

Liposomes composed of DOPE (1,2-dioleoyl-sn-glycero-3-phosphoethanolamine), DOPC(1,2-dioleoyl- sn-glycero-3-phosphocholine), cholesterol and sphingomyelin in a molar ratio1/1/3/1, were prepared by the freeze-thaw and extrusion method. 1μM protein was mixed with1 mM freshly prepared liposomes and incubated for 1h at 25°C in 100 mL PBS. Samples were adjusted to a final concentration of 40% Optiprep™ (in PBS), loaded in centrifuge tubes and overlaid with 4.5 mL 20% Optiprep™ and 0.3 mL PBS. Centrifugations were performed overnight at 4°C and 192000 x g on SW55ti rotor. Top and bottom fractions of the gradient were analyzed by immunoblotting using anti-Strep tag antibody.

### Illustrations {#sec4.4.6}

Cartoon representations were made with PyMol ([@bib58].). The HAP2 amino acid sequence alignments displayed were made by MUSCLE ([@bib19]) and rendered with ESPript 3.0 ([@bib54]). The organisms represented in [Figure 2](#fig2){ref-type="fig"} have the following abreviations: *Chlamydomonas reinhardtii* (Cr), *Gonium pectoral* (Gp), *Volvox carterii* (forms A and B; VcA and VcB respectively), *Monoraphidium neglectum* (Mn), *Coccomyxa subellipsoidea*, (Cs), *Auxenochlorella protothecoides* (Ap), *Chlorella variabilis* (Cv), *Chlorella sorokiniana* (Csor) and *Micractinium conductrix* (Mc).

Quantification and Statistical Analysis {#sec4.5}
---------------------------------------

Densitometry analysis of western blots from liposome co-flotation assays was performed with ImageJ software ([@bib57]) and expressed as percentage of HAP2e in top and bottom fractions of iodixanol gradients. Results are shown as mean ± SD of three independent experiments (n=3). Differences in liposome binding between HAP2e WT and mutants were analyzed by a Student's t-test (P\<0.05, ^∗^; P\<0.01, ^∗∗^).

Data and Software Availability {#sec4.6}
------------------------------

The accession number for the *Chlamydomonas reinhardtii* HAP2 structure reported in this paper is PDB: [6E18](pdb:6E18){#intref0150}.
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